| For: | Qiao SB, Niu ML, Liang WT, Zhang LJ, Chen X, Zhu YK. Analysis of serum S100A12, soluble advanced glycation end products receptor, and gut microbiome in elderly patients with colorectal cancer. World J Gastrointest Oncol 2025; 17(6): 106393 [PMID: 40547164 DOI: 10.4251/wjgo.v17.i6.106393] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v17/i6/106393.htm |
| Number | Citing Articles |
| 1 |
Gang Li, Hao-Sheng Gong, Ming-Jing Zhao, Biao Hu, Zhen Wan, Ming-Zhi Ling. Associations between serum biomarkers and gut microbial imbalance in predicting chemotherapy response in colorectal cancer: A retrospective analysis. World Journal of Gastrointestinal Oncology 2025; 17(8): 108870 doi: 10.4251/wjgo.v17.i8.108870
|
| 2 |
Junhua Guo, Xuefei Yang, Yinyan Shao, Zimeng Li, Zhifeng Ye, Keke Hu, Ting Huang, Heran Zhou. Integrated Bioinformatics and Experimental Analyses Reveal S100A12 as a Biomarker and Therapeutic Target in Cholangiocarcinoma. The FASEB Journal 2026; 40(9) doi: 10.1096/fj.202600318R
|
| 3 |
Yuhang Fang, Shuhan Yang, Yi Xie, Yan Wang, Bailu Sui, Yu Chen, Xinhe Yuan, Ying Zhang. Microbiota in the Tumor Metastatic Cascade: Emerging Evidence Across Invasion, Circulation, and Colonization. International Journal of Molecular Sciences 2026; 27(14) doi: 10.3390/ijms27146308
|
| 4 |
Yeling He, Tinghui Li, Hui Sun, Jing Yang. Stage-Specific carcinogenic mechanisms and intervention strategies for pks+ Escherichia coli–associated colorectal cancer. Archives of Microbiology 2026; 208(9) doi: 10.1007/s00203-026-05023-0
|